a. Patients who require invasive or non-invasive (including CPAP and high flow nasal cannula) ventilation at the time of inclusion. <br/ >b. AST/ALT values >5 fold the ULN. <br/ >c. Documented impairment of renal function <br/ >d. Absolute neutrophil count below 500 cells/mm3 <br/ >e. Absolute platelet count below 50,000 cells/mm3 <br/ >f. Documented sepsis or high suspicion of superimposed severe bacterial or fungal infection <br/ >g. Comorbidities or concomitant medications likely to be incompatible for cotrimoxazole use <br/ >h. Pregnancy or lactation. <br/ >i. History of cotrimoxazole hypersensitivity <br/ >j. Patients participating in another clinical trial for SARS-CoV-2 infection <br/ >

a. Patients who require invasive or non-invasive (including CPAP and high flow nasal cannula) ventilation at the time of inclusion. <br/ >b. AST/ALT values >5 fold the ULN. <br/ >c. Documented impairment of renal function <br/ >d. Absolute neutrophil count below 500 cells/mm3 <br/ >e. Absolute platelet count below 50,000 cells/mm3 <br/ >f. Documented sepsis or high suspicion of superimposed severe bacterial or fungal infection <br/ >g. Comorbidities or concomitant medications likely to be incompatible for cotrimoxazole use <br/ >h. Pregnancy or lactation. <br/ >i. History of cotrimoxazole hypersensitivity <br/ >j. Patients participating in another clinical trial for SARS-CoV-2 infection <br/ >

N/A

N/A

a. Patients who require invasive or non-invasive (including CPAP and high flow nasal cannula) ventilation at the time of inclusion. <br/ >b. AST/ALT values >5 fold the ULN. <br/ >c. Documented impairment of renal function <br/ >d. Absolute neutrophil count below 500 cells/mm3 <br/ >e. Absolute platelet count below 50,000 cells/mm3 <br/ >f. Documented sepsis or high suspicion of superimposed severe bacterial or fungal infection <br/ >g. Comorbidities or concomitant medications likely to be incompatible for cotrimoxazole use <br/ >h. Pregnancy or lactation. <br/ >i. History of cotrimoxazole hypersensitivity <br/ >j. Patients participating in another clinical trial for SARS-CoV-2 infection <br/ >

a. Patients who require invasive or non-invasive (including CPAP and high flow nasal cannula) ventilation at the time of inclusion. <br/ >b. AST/ALT values >5 fold the ULN. <br/ >c. Documented impairment of renal function <br/ >d. Absolute neutrophil count below 500 cells/mm3 <br/ >e. Absolute platelet count below 50,000 cells/mm3 <br/ >f. Documented sepsis or high suspicion of superimposed severe bacterial or fungal infection <br/ >g. Comorbidities or concomitant medications likely to be incompatible for cotrimoxazole use <br/ >h. Pregnancy or lactation. <br/ >i. History of cotrimoxazole hypersensitivity <br/ >j. Patients participating in another clinical trial for SARS-CoV-2 infection <br/ >